AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Bone Biologics Corp Director's Dealing 2024

Jan 10, 2024

35440_dirs_2024-01-10_2cdf0eac-06db-40bc-80cd-eb485c50da18.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2024-01-08

Reporting Person: Gagnon Robert E. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct